Verastem Obtains $32,000,000 Series B Financing Round

  • Feed Type
  • Date
    7/14/2011
  • Company Name
    Verastem
  • Mailing Address
    215 First Street Cambridge, MA 02142
  • Company Description
    Verastem, Inc. is a private biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells.
  • Website
    http://www.Verastem.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $32,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development.
  • M&A Terms
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    Astellas Venture Management
  • Venture Investor
    Longwood Founders Fund
  • Venture Investor
    Longwood Founders Fund
  • Venture Investor
    Bessemer Venture Partners
  • Venture Investor
    MPM Capital
  • Venture Investor
    Cardinal Partners

By posting a comment, you agree to our terms and conditions.